This German Biotech Is Using AI To Help Researchers Develop Cures Quicker

The increased use of artificial intelligence and machine learning is steadily shifting the paradigm of medical research and treatment, providing researchers real-time access to every white paper and clinical case study conducted on a genetic disorder. Being able to develop such an elaborate database of information allows researchers to not only understand the full scope of a medical condition, but further shorten the amount of time it takes to develop a cure.

Founded in 2011, Innoplexus is a technology and product development company focused on solving complex challenges in the pharmaceutical and life sciences industries.

Back to news